Exploratory Study for the Validity of QuQu Scale

• Register: ClinicalTrials.gov
• Last refreshed on: 8 August 2016
• Main ID: NCT02267486
• Date of registration: 14/10/2014
• Prospective Registration: No
• Primary sponsor: Translational Research Informatics Center, Kobe, Hyogo, Japan
• Public title: Exploratory Study for the Validity of QuQu Scale QuQu
• Scientific title: Exploratory Study for the Validity of a Novel Dementia Rating Scale (QUick QUestion Scale) for Alzheimer's Disease Dementia
• Date of first enrolment: October 2014
• Target sample size: 972
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/show/NCT02267486
• Study type: Observational
• Study design: Time Perspective: Prospective
• Phase: N/A

Countries of recruitment

Japan

Contacts

• Name: Yu Nakamura
• Affiliation: Kagawa University School of Medicine

Key inclusion & exclusion criteria

Inclusion Criteria:

1. Alzheimer Dementia (AD) patients and patients with cognitive concern without dementia

2. Written Informed consent by each subject and/or a legal representative, and study
informant. If the doctor decides that the patient has no trouble in understanding
this study, the written informed consent of a legal representative may be exempted.
If not, this study needs a written informed consent by a legal representative and the
patient except the case where the consent is hardly obtained due to the progression
of the disease.

Exclusion Criteria:

1. patients with other types of dementia (e.g. vascular dementia, Levy body dementia,
frontotemporal dementia)

2. patients with other diseases which cause secondary dementia prior to Alzheimer
Dementia (AD)

3. patients with other severe neurological disease or psychiatric disorder without
Alzheimer Dementia (AD)

4. patients with other medical conditions where the investigators determine that it is
inappropriate for the subject of this study (e.g. inappropriate for the evaluation of
dementia rating scale)



Age minimum: N/A
Age maximum: N/A
Gender: Both

Health Condition(s) or Problem(s) studied

Alzheimer Dementia

Intervention(s)

Other: Standard therapy of Alzheimer Dementia (AD)

Other: Observation

Primary Outcome(s)

Novel Dementia Rating Scale (QUick QUestion Scale) [Time Frame: 1 day]

Secondary ID(s)

UMIN000016394

TRIAD1402

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

Daiichi Sankyo Co., Ltd.